Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLX-PAD for Gluteal Muscle Regeneration After THA
NCT01525667Phase 2Completed
- Sponsor
- Pluri Inc.
- Start
- Nov 2012
- Primary completion
- Dec 2013
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of PLX-PAD in muscle injury, sponsored by Pluri Inc.. Started Nov 2012; status: completed.
02
Drugs
PLX-PAD
03
Conditions
muscle injury
Beyond the preview
Go deeper on NCT01525667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525667.